Atazanavir sulfate
Reyataz (atazanavir sulfate) is a small molecule pharmaceutical. Atazanavir sulfate was first approved as Reyataz on 2004-03-01. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections.
| Trade Name | Reyataz |
|---|---|
| Common Name | Atazanavir sulfate |
| Indication | acquired immunodeficiency syndrome, hiv infections |
| Drug Class | Antivirals: HIV protease inhibitors (saquinavir type) |
